AAAAAA

   
Results: 1-14 |
Results: 14
Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene
Authors: Casimiro, DR Tang, AM Perry, HC Long, RS Chen, MC Heidecker, GJ Davies, ME Freed, DC Persaud, NV Dubey, S Smith, JG Havlir, D Richman, D Chastain, MA Simon, AJ Fu, TM Emini, EA Shiver, JW
Citation: Dr. Casimiro et al., Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene, J VIROLOGY, 76(1), 2002, pp. 185-194
Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors
Authors: Kemper, CA Witt, MD Keiser, PH Dube, MP Forthal, DN Leibowitz, M Smith, DS Rigby, A Hellmann, NS Lie, YS Leedom, J Richman, D McCutchan, JA Haubrich, R
Citation: Ca. Kemper et al., Sequencing of protease inhibitor therapy: insights from an analysis of HIVphenotypic resistance in patients failing protease inhibitors, AIDS, 15(5), 2001, pp. 609-615
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection
Authors: Schacker, T Little, S Connick, E Gebhard, K Zhang, ZQ Krieger, J Pryor, J Havlir, D Wong, JK Schooley, RT Richman, D Corey, L Haase, AT
Citation: T. Schacker et al., Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection, J INFEC DIS, 183(4), 2001, pp. 555-562
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy
Authors: Huang, W De Gruttola, V Fischl, M Hammer, S Richman, D Havlir, D Gulick, R Squires, K Mellors, J
Citation: W. Huang et al., Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy, J INFEC DIS, 183(10), 2001, pp. 1455-1465
Effects of the high-probability request procedure: Patterns of responding to low-probability requests
Authors: McComas, JJ Wacker, DP Cooper, LJ Peck, S Golonka, Z Millard, T Richman, D
Citation: Jj. Mccomas et al., Effects of the high-probability request procedure: Patterns of responding to low-probability requests, J DEV PHY D, 12(2), 2000, pp. 157-171
Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis
Authors: Babiker, A Bartlett, J Breckenridge, A Collins, G Coombs, R Cooper, D Creagh, T Cross, A Daniels, M Darbyshire, J Dawson, D DeGruttola, V DeMasi, R Dolin, R Eron, J Fischl, M Grossberg, S Hamilton, J Hammer, S Hartigan, P Henry, K Hill, A Hughes, M Kahn, J Katlama, C Katzenstein, D Kim, S Mildvan, D Montaner, J Moore, M Neaton, J O'Brien, W Ribaudo, H Richman, D Saag, M Salgo, M Saravolatz, L Schooley, R Seligmann, M Staszewski, S Struthers, L Tierney, C Tsiatis, A Welles, S
Citation: A. Babiker et al., Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis, AIDS RES H, 16(12), 2000, pp. 1123-1133
The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection
Authors: Binley, JM Trkola, A Ketas, T Schiller, D Clas, B Little, S Richman, D Hurley, A Markowitz, M Moore, JP
Citation: Jm. Binley et al., The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection, J INFEC DIS, 182(3), 2000, pp. 945-949
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timingof antiretroviral therapy
Authors: Schacker, T Little, S Connick, E Gebhard-Mitchell, K Zhang, ZQ Krieger, J Pryor, J Havlir, D Wong, JK Richman, D Corey, L Haase, AT
Citation: T. Schacker et al., Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: Implications for timingof antiretroviral therapy, J INFEC DIS, 181(1), 2000, pp. 354-357
The effects of presession exposure to attention on the results of assessments of attention as a reinforcer
Authors: Berg, WK Peck, S Wacker, DP Harding, J McComas, J Richman, D Brown, K
Citation: Wk. Berg et al., The effects of presession exposure to attention on the results of assessments of attention as a reinforcer, J APPL BE A, 33(4), 2000, pp. 463-477
Functional analysis of aberrant behavior through measurement of separate response topographies
Authors: Derby, KM Hagopian, L Fisher, WW Richman, D Augustine, M Fahs, A Thompson, R
Citation: Km. Derby et al., Functional analysis of aberrant behavior through measurement of separate response topographies, J APPL BE A, 33(1), 2000, pp. 113-117
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviralexperience
Authors: Haubrich, R Thompson, M Schooley, R Lang, W Stein, A Sereni, D van der Ende, ME Antunes, F Richman, D Pagano, G Kahl, L Fetter, A Brown, DJ Clumeck, N
Citation: R. Haubrich et al., A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviralexperience, AIDS, 13(17), 1999, pp. 2411-2420
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence
Authors: Abrams, D Allan, D Antunes, F Breckenridge, A Bruun, J Cameron, W Carbon, C Chalmers, I Chang, H Chodakewitz, J Clendenin, N Clumeck, N Collier, A Collins, G Cooper, E Cooper, D Danner, S D'Aquila, R DeGruttola, V DeMasi, R Dee, L Deyton, L Dixon, D Farthing, C Feinberg, J Fischl, M Flepp, M Gartland, M Gatell, J Gazzard, B Goebel, F Gotzsche, P Gringeri, A Hall, D Hamilton, J Hammer, S Hartigan, P Heath-Chiozzi, M Henry, K Hill, A Hirschel, B Ioannidis, J Kahn, J Katlama, C Katzenstein, D Killen, J King, E de Loes, SK Kravcik, S Lange, J Leavitt, R Leonard, J Maeland, A Mannucci, P Mathiesen, L McDade, H Meibohn, A Melander, H Merigan, T Mulder, J Myers, M Neaton, J Nessling, M Perrin, L Pettinelli, C Phair, J Phillips, A Pinching, A Poppa, A Power, L Reiss, P Richman, D Rooney, J Rousseau, F Rutherford, G Salgo, M Sandstrom, E Saravolatz, L Savidge, G Schnittman, S Schooley, R Seligmann, M Simberkoff, M Skowron, G Slade, P Smith, D Smith, RP Soriano, V Stanley, K Stingl, G Stoffels, P Struthers, L Tierney, C Thompson, M Van der Broeck, R Van Leeuven, R Van Weverling, G Veenstra, J Vella, S Volberding, P Weber, J Winslow, D Yeni, P Yeo, J Dormont, J Sande, M Weller, I Babiker, A Collins, R Darbyshire, J Duncan, W Foulkes, M Hughes, M Peto, R Peto, T Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025
Nevirapine, didanosine, and zidovudine for patients with HIV: The INCAS trial
Authors: Haubrich, R Richman, D
Citation: R. Haubrich et D. Richman, Nevirapine, didanosine, and zidovudine for patients with HIV: The INCAS trial, J AM MED A, 281(2), 1999, pp. 130-131
The challenge of immune control of immunodeficiency virus
Authors: Richman, D
Citation: D. Richman, The challenge of immune control of immunodeficiency virus, J CLIN INV, 104(6), 1999, pp. 677-678
Risultati: 1-14 |